Cleared Traditional

ADVIA IMS CARBAMAZEPINE METHOD

K042808 · Bayer Healthcare, LLC · Chemistry
Feb 2005
Decision
119d
Days
Class 2
Risk

About This 510(k) Submission

K042808 is an FDA 510(k) clearance for the ADVIA IMS CARBAMAZEPINE METHOD, a Enzyme Immunoassay, Carbamazepine (Class II — Special Controls, product code KLT), submitted by Bayer Healthcare, LLC (New York, US). The FDA issued a Cleared decision on February 8, 2005, 119 days after receiving the submission on October 12, 2004. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.3645.

Submission Details

510(k) Number K042808 FDA.gov
FDA Decision Cleared SESE
Date Received October 12, 2004
Decision Date February 08, 2005
Days to Decision 119 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code KLT — Enzyme Immunoassay, Carbamazepine
Device Class Class II — Special Controls
CFR Regulation 21 CFR 862.3645

Similar Devices — KLT Enzyme Immunoassay, Carbamazepine

All 55
Carbamazepine Gen 4
K151578 · Roche Diagnostics Operations (Rdo) · Oct 2015
ABBOTT CARBAMAZEPINE ASSAY
K123518 · Microgenics Corporation · Jun 2013
ARCHITECT ICARBAMAZEPINE ICARBAMAZEPINE REAGENTS; ARCHITECT ICARBAMAZEPINE CALIBRATORS
K103627 · Abbott Laboratories · Oct 2011
CARBAMAZEPINE, VALPROIC ACID, TDM CALIBRATION SET B AND ABTROL, NORTROL CONTROLS
K063131 · Thermo Electron OY · Oct 2007
ONLINE TDM CARBAMAZEPINE
K031902 · Roche Diagnostics Corp. · Sep 2003
RANDOX CARBAMAZEPINE
K011648 · Randox Laboratories, Ltd. · Jan 2002